Loss and Recovery of Genetic Diversity in Adapting Populations of HIV

The evolution of drug resistance in HIV occurs by the fixation of specific, well-known, drug-resistance mutations, but the underlying population genetic processes are not well understood. By analyzing within-patient longitudinal sequence data, we make four observations that shed a light on the underlying processes and allow us to infer the short-term effective population size of the viral population in a patient. Our first observation is that the evolution of drug resistance usually occurs by the fixation of one drug-resistance mutation at a time, as opposed to several changes simultaneously. Second, we find that these fixation events are accompanied by a reduction in genetic diversity in the region surrounding the fixed drug-resistance mutation, due to the hitchhiking effect. Third, we observe that the fixation of drug-resistance mutations involves both hard and soft selective sweeps. In a hard sweep, a resistance mutation arises in a single viral particle and drives all linked mutations with it when it spreads in the viral population, which dramatically reduces genetic diversity. On the other hand, in a soft sweep, a resistance mutation occurs multiple times on different genetic backgrounds, and the reduction of diversity is weak. Using the frequency of occurrence of hard and soft sweeps we estimate the effective population size of HIV to be ( confidence interval ). This number is much lower than the actual number of infected cells, but much larger than previous population size estimates based on synonymous diversity. We propose several explanations for the observed discrepancies. Finally, our fourth observation is that genetic diversity at non-synonymous sites recovers to its pre-fixation value within 18 months, whereas diversity at synonymous sites remains depressed after this time period. These results improve our understanding of HIV evolution and have potential implications for treatment strategies.

[1]  J. Falloon,et al.  Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites , 1997, Journal of virology.

[2]  Y X Fu,et al.  Estimating mutation rate and generation time from longitudinal samples of DNA sequences. , 2001, Molecular biology and evolution.

[3]  F. Nosten,et al.  Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. , 2006, Molecular biology and evolution.

[4]  R. Sanjuán,et al.  Interplay between RNA structure and protein evolution in HIV-1. , 2011, Molecular biology and evolution.

[5]  T. Leitner,et al.  Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Nagylaki Introduction to Theoretical Population Genetics , 1992 .

[7]  D. Richman,et al.  2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.

[8]  Adam Kiezun,et al.  Deleterious Alleles in the Human Genome Are on Average Younger Than Neutral Alleles of the Same Frequency , 2013, PLoS genetics.

[9]  Aleksandra M Walczak,et al.  The Structure of Genealogies in the Presence of Purifying Selection: A Fitness-Class Coalescent , 2010, Genetics.

[10]  J. Coffin,et al.  Linkage disequilibrium test implies a large effective population number for HIV in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Michael M. Desai,et al.  Beneficial Mutation–Selection Balance and the Effect of Linkage on Positive Selection , 2006, Genetics.

[12]  N L Kaplan,et al.  The "hitchhiking effect" revisited. , 1989, Genetics.

[13]  I. Gordo,et al.  Nonequilibrium model for estimating parameters of deleterious mutations. , 2005, Physical review. E, Statistical, nonlinear, and soft matter physics.

[14]  Michael M. Desai,et al.  Dynamic Mutation–Selection Balance as an Evolutionary Attractor , 2012, Genetics.

[15]  J. Coffin,et al.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.

[16]  D. Richman,et al.  Update of the drug resistance mutations in HIV-1: December 2010. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[17]  C. Wilke,et al.  The traveling-wave approach to asexual evolution: Muller's ratchet and speed of adaptation. , 2007, Theoretical population biology.

[18]  A. Haase The Role of Active and Covert Infections in Lentivirus Pathogenesis , 1994, Annals of the New York Academy of Sciences.

[19]  B. Shraiman,et al.  Rate of Adaptation in Large Sexual Populations , 2010, Genetics.

[20]  Pleuni Simone Pennings,et al.  Standing Genetic Variation and the Evolution of Drug Resistance in HIV , 2011, PLoS Comput. Biol..

[21]  Sebastian Bonhoeffer,et al.  Stochastic or deterministic: what is the effective population size of HIV-1? , 2006, Trends in microbiology.

[22]  M. Nei,et al.  THE BOTTLENECK EFFECT AND GENETIC VARIABILITY IN POPULATIONS , 1975, Evolution; international journal of organic evolution.

[23]  S. Hughes,et al.  Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication , 2010, Journal of Virology.

[24]  L. M. Mansky,et al.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.

[25]  Rebecca Batorsky,et al.  Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection , 2011, Proceedings of the National Academy of Sciences.

[26]  Philipp W. Messer,et al.  Evidence that Adaptation in Drosophila Is Not Limited by Mutation at Single Sites , 2010, PLoS genetics.

[27]  Benjamin H. Good,et al.  Distribution of fixed beneficial mutations and the rate of adaptation in asexual populations , 2012, Proceedings of the National Academy of Sciences.

[28]  Ryan D. Hernandez,et al.  Proportionally more deleterious genetic variation in European than in African populations , 2008, Nature.

[29]  John Maynard Smith,et al.  The hitch-hiking effect of a favourable gene. , 1974, Genetical research.

[30]  Eric J. Hayden,et al.  Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme , 2011, Nature.

[31]  G. R. Fraser,et al.  The mathematics of heredity , 1971 .

[32]  Thomas Leitner,et al.  Recombination Rate and Selection Strength in HIV Intra-patient Evolution , 2009, PLoS Comput. Biol..

[33]  B. Shraiman,et al.  Genetic Draft and Quasi-Neutrality in Large Facultatively Sexual Populations , 2011, Genetics.

[34]  R. Stephens,et al.  HIV Populations Are Large and Accumulate High Genetic Diversity in a Nonlinear Fashion , 2013, Journal of Virology.

[35]  A. J. Brown,et al.  Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Raul Andino,et al.  The role of mutational robustness in RNA virus evolution , 2013, Nature Reviews Microbiology.

[37]  S. Frost,et al.  Evolution of Lamivudine Resistance in Human Immunodeficiency Virus Type 1-Infected Individuals: the Relative Roles of Drift and Selection , 2000, Journal of Virology.

[38]  Gergely J. Szöllősi,et al.  Emergent Neutrality in Adaptive Asexual Evolution , 2011, Genetics.

[39]  J. Hermisson,et al.  Soft sweeps II--molecular population genetics of adaptation from recurrent mutation or migration. , 2006, Molecular biology and evolution.

[40]  Yun S. Song,et al.  A Simple Method for Finding Explicit Analytic Transition Densities of Diffusion Processes with General Diploid Selection , 2012, Genetics.

[41]  Joachim Hermisson,et al.  Soft Sweeps III: The Signature of Positive Selection from Recurrent Mutation , 2006, PLoS genetics.

[42]  Daniel B. Weissman,et al.  Limits to the Rate of Adaptive Substitution in Sexual Populations , 2012, PLoS genetics.

[43]  J. Coffin,et al.  The solitary wave of asexual evolution , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  James P. Hughes,et al.  Mutation of HIV-1 Genomes in a Clinical Population Treated with the Mutagenic Nucleoside KP1461 , 2011, PloS one.

[45]  Michael M. Desai,et al.  Genetic Diversity and the Structure of Genealogies in Rapidly Adapting Populations , 2012, Genetics.

[46]  L. Bacheler,et al.  Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy , 2000, Antimicrobial Agents and Chemotherapy.

[47]  Igor M Rouzine,et al.  Multi-site adaptation in the presence of infrequent recombination. , 2010, Theoretical population biology.

[48]  J. Mellors,et al.  Ultrasensitive Allele-Specific PCR Reveals Rare Preexisting Drug-Resistant Variants and a Large Replicating Virus Population in Macaques Infected with a Simian Immunodeficiency Virus Containing Human Immunodeficiency Virus Reverse Transcriptase , 2012, Journal of Virology.